Alnylam Pharmaceuticals, Inc. (ETR:DUL)
Germany
· Delayed Price · Currency is EUR 274.80
-1.70 (-0.61%)
Mar 9, 2026, 5:35 PM CET
Alnylam Pharmaceuticals Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 36,667 | 44,744 | 29,316 | 21,731 | 27,358 | 17,834 | Upgrade
|
| Market Cap Growth | 18.09% | 52.63% | 34.90% | -20.57% | 53.40% | 44.47% | Upgrade
|
| Enterprise Value | 36,719 | 44,786 | 29,263 | 21,965 | 27,663 | 17,475 | Upgrade
|
| Last Close Price | 274.20 | 335.40 | - | 227.20 | 227.20 | 150.30 | Upgrade
|
| PE Ratio | 137.22 | 167.44 | - | - | - | - | Upgrade
|
| PS Ratio | 11.59 | 14.15 | 13.50 | 13.14 | 28.18 | 24.02 | Upgrade
|
| PB Ratio | 54.55 | 66.57 | 452.40 | -108.87 | -184.79 | 34.48 | Upgrade
|
| P/TBV Ratio | 54.55 | 66.57 | 452.40 | - | - | 34.48 | Upgrade
|
| P/FCF Ratio | 92.51 | 112.89 | - | 572.67 | - | - | Upgrade
|
| P/OCF Ratio | 82.15 | 100.24 | - | 230.62 | - | - | Upgrade
|
| EV/Sales Ratio | 11.47 | 14.16 | 13.48 | 13.28 | 28.50 | 23.54 | Upgrade
|
| EV/EBITDA Ratio | 67.43 | 94.37 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 84.91 | 104.84 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 92.64 | 112.99 | - | 578.81 | - | - | Upgrade
|
| Debt / Equity Ratio | 3.76 | 3.76 | 40.89 | -12.16 | -16.51 | 3.72 | Upgrade
|
| Debt / EBITDA Ratio | 4.70 | 4.70 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 6.38 | 6.38 | - | 63.96 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.08 | 0.08 | 0.73 | -1.10 | -2.65 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.11 | 0.11 | -0.41 | -1.07 | -0.57 | 0.38 | Upgrade
|
| Net Debt / FCF Ratio | 0.13 | 0.13 | -1.15 | 5.80 | -0.68 | 0.35 | Upgrade
|
| Asset Turnover | 0.81 | 0.81 | 0.56 | 0.50 | 0.29 | 0.24 | Upgrade
|
| Inventory Turnover | 8.46 | 8.46 | 3.86 | 2.85 | 1.57 | 1.74 | Upgrade
|
| Quick Ratio | 2.51 | 2.51 | 2.61 | 2.86 | 3.17 | 3.79 | Upgrade
|
| Current Ratio | 2.76 | 2.76 | 2.78 | 3.08 | 3.51 | 4.04 | Upgrade
|
| Return on Equity (ROE) | 73.28% | 73.28% | - | - | -526.14% | -106.31% | Upgrade
|
| Return on Assets (ROA) | 6.81% | 6.81% | -2.74% | -4.78% | -13.65% | -12.56% | Upgrade
|
| Return on Invested Capital (ROIC) | 86.03% | 100.88% | -255.24% | -198.35% | -261.58% | -132.10% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.30% | 14.30% | -5.80% | -9.90% | -28.30% | -24.00% | Upgrade
|
| Earnings Yield | 0.73% | 0.60% | -0.92% | -1.83% | -3.87% | -4.21% | Upgrade
|
| FCF Yield | 1.08% | 0.89% | -0.14% | 0.18% | -2.10% | -3.54% | Upgrade
|
| Buyback Yield / Dilution | -5.51% | -5.51% | -2.20% | -2.64% | -2.73% | -3.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.